{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T03:19:16Z","timestamp":1782184756847,"version":"3.54.5"},"reference-count":23,"publisher":"Frontiers Media SA","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1344,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1111\/j.1432-2277.2011.01409.x","type":"journal-article","created":{"date-parts":[[2011,12,27]],"date-time":"2011-12-27T09:20:19Z","timestamp":1324977619000},"page":"391-400","source":"Crossref","is-referenced-by-count":19,"title":["Conversion to tacrolimus once-daily from ciclosporin in stable kidney transplant recipients: a multicenter study"],"prefix":"10.3389","volume":"25","author":[{"given":"Lionel","family":"Rostaing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"S\u00e1nchez-Fructuoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Glyda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk R.","family":"Kuypers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen\u00f6","family":"Jaray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2011,12,27]]},"reference":[{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/TP.0b013e318186dd0c","article-title":"Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure","volume":"86","author":"Jevnikar","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/TP.0b013e31816b4388","article-title":"Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF study","volume":"85","author":"Shihab","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1097\/01.ASN.0000071515.27754.67","article-title":"Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus","volume":"14","author":"Arzt","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1600-6143.2004.00427.x","article-title":"Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile","volume":"4","author":"Arzt","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.transproceed.2006.08.070","article-title":"Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study","volume":"38","author":"Marcen","year":"2006","journal-title":"Transpl Proc"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1432-2277.2005.00154.x","article-title":"Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects","volume":"18","author":"Margreiter","year":"2005","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0041-1345(98)00229-2","article-title":"Conversion from Neoral\u00ae (ciclosporin) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis","volume":"30","author":"Busque","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/00007890-200003270-00029","article-title":"The effect of conversion from ciclosporin to tacrolimus on gingival hyperplasia, hirsutism and cholesterol","volume":"69","author":"Thorp","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.transproceed.2005.02.095","article-title":"Conversion from cyclosporine to tacrolimus results in improved creatinine but does not alter lipid profile","volume":"37","author":"Woodside","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/01.tp.0000220480.84449.71","article-title":"Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial","volume":"81","author":"Meier","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1399-0012.2005.00389.x","article-title":"Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure","volume":"19","author":"Waid","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/j.1600-6143.2009.02794.x","article-title":"Pharmacokinetics for once-versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial","volume":"9","author":"Wlodarczyk","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/01.TP.0000119349.70491.F9","article-title":"Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients","volume":"77","author":"Baid-Agrawal","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1681\/ASN.V122368","article-title":"Cardiovascular risk factors in renal transplant patients: cyclosporine A versus tacrolimus","volume":"12","author":"Ligtenberg","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.transproceed.2005.03.135","article-title":"Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients","volume":"37","author":"Pohanka","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/TP.0b013e3181e9feda","article-title":"Reduced CO concentrations and increased dose requirements in renal allograft recipients converted to the novel once-daily tacrolimus formulation","volume":"90","author":"de Jonge","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/j.1600-6143.2004.00579.x","article-title":"Performance of different prediction equations for estimating renal function in kidney transplantation","volume":"4","author":"Gaspari","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jama.295.10.1152","article-title":"Reporting of non-inferiority and equivalence randomized trials: an extension of the CONSORT statement","volume":"295","author":"Piaggio","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1111\/j.1600-6143.2010.03256.x","article-title":"Tacrolimus once daily (Advagraf) versus twice daily (Prograf) in de novo renal transplantation: a randomized phase III study","volume":"10","author":"Kr\u00e4mer","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2011.01409.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1097\/01.tp.0000264056.20105.b4","article-title":"Two years postconversion from a Prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients","volume":"83","author":"Alloway","year":"2007","journal-title":"Transplantation"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1432-2277.2011.01409.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1432-2277.2011.01409.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:39:24Z","timestamp":1641062364000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1432-2277.2011.01409.x"}},"subtitle":["Ciclosporin to tacrolimus once-daily conversion in renal transplantation"],"short-title":[],"issued":{"date-parts":[[2011,12,27]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1432-2277.2011.01409.x","relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12,27]]}}}